ScripJazz and Roche can both expect a sales boost after a combination of their drugs has improved overall survival in extensive-stage small-cell lung cancer (SCLC). Full data from the Phase III IMforte tri
Generics BulletinWith a jury trial previously set to begin later this month, Hikma has reached a preliminary agreement under which it would pay $50m to resolve certain class action antitrust lawsuits brought against t
Pink SheetPharmaMar and Boehringer Ingelheim are the latest companies to ask the European Medicines Agency to fast track its review of their planned EU marketing authorization applications (MAAs) for their resp
Pink SheetAlyftrek (vanzacaftor/tezacaftor/deutivacaftor), Vertex Pharmaceuticals’ next generation treatment for cystic fibrosis (CF) is one of six orphan products that the European Medicines Agency backed for